Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q

(Mark One)

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended  September 30, 2002        

or

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________

Commission file number   0-16752

MEDSTONE INTERNATIONAL, INC.


(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE

 

66-0439440


 


(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

100 Columbia, Suite 100, Aliso Viejo,  California

 

92656


 


(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code:          (949) 448-7700

 

 

 

Not Applicable


(Former name, former address and former fiscal year, if changed, since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes

x

No

o

 

The number of shares of the Common Stock of the registrant outstanding as of November 11, 2002 was 3,758,220.



Table of Contents

MEDSTONE INTERNATIONAL, INC.

INDEX TO FORM 10-Q

 

 

Page No.

 

 


PART I.     FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements:

 

 

 

 

 

Consolidated Balance Sheets
September 30, 2002 (Unaudited) and December 31, 2001

3

 

 

 

 

Condensed Consolidated Statements of Income (Unaudited)
Three and Nine Months Ended September 30, 2002 and 2001

4

 

 

 

 

Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)
Nine Months Ended September 30, 2002

5

 

 

 

 

Condensed Consolidated Statements of Cash Flows (Unaudited)
Nine Months ended September 30, 2002 and 2001

6

 

 

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

7

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

10

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

14

 

 

 

Item 4.

Controls and Procedures

15

 

 

 

PART II.     OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

16

 

 

 

Item 2.

Changes in Securities

16

 

 

 

Item 3.

Defaults Upon Senior Securities

16

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

16

 

 

 

Item 5.

Other Information

16

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

16

 

 

 

Signatures

17

 

 

Certifications

 

2



Table of Contents

MEDSTONE INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

 

 

September 30,
2002

 

December 31,
2001

 

 

 



 



 

 

 

 

(Unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,739,324

 

$

1,928,731

 

 

Short-term investments held to maturity

 

 

4,305,503

 

 

4,570,420

 

 

Accounts receivable, less allowance for doubtful accounts of $840,220 and $804,646 at September 30, 2002 and December 31, 2001, respectively

 

 

3,945,773

 

 

4,013,781

 

 

Inventories, less allowance for inventory obsolescence of $440,712 and $540,417 at September 30, 2002 and December 31, 2001, respectively

 

 

6,064,828

 

 

6,296,069

 

 

Deferred tax assets

 

 

2,160,695

 

 

2,160,695

 

 

Prepaid expenses and other current assets

 

 

474,025

 

 

541,194

 

 

 

 



 



 

 

Total current assets

 

 

18,690,148

 

 

19,510,890

 

Buildings, property and equipment, at cost:

 

 

 

 

 

 

 

 

Building

 

 

359,324

 

 

359,324

 

 

Lithotripters

 

 

13,569,744

 

 

13,163,285

 

 

Equipment

 

 

2,368,810

 

 

2,048,582

 

 

Furniture and fixtures

 

 

999,452

 

 

961,776

 

 

Leasehold improvements

 

 

175,032

 

 

171,177

 

 

 

 



 



 

 

 

 

 

17,472,362

 

 

16,704,144

 

 

Less accumulated depreciation and amortization

 

 

(13,236,592

)

 

(12,041,254

)

 

 

 



 



 

 

Net property and equipment

 

 

4,235,770

 

 

4,662,890

 

 

 



 



 

Goodwill, net

 

 

3,187,708

 

 

3,205,251

 

Investment in unconsolidated subsidiaries

 

 

879,133

 

 

909,492

 

Net investment in sale-type lease

 

 

217,488

 

 

224,731

 

Other assets, net

 

 

102,096

 

 

117,006

 

 

 



 



 

 

 

$

27,312,343

 

$

28,630,260

 

 

 



 



 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,166,488

 

$

1,087,594

 

 

Accrued expenses

 

 

228,628

 

 

345,075

 

 

Accrued income taxes

 

 

211,102

 

 

—  

 

 

Accrued payroll expenses

 

 

435,596

 

 

313,472

 

 

Customer deposits

 

 

80,912

 

 

364,048

 

 

Deferred revenue

 

 

679,736

 

 

783,948

 

 

 



 



 

 

Total current liabilities

 

 

2,802,462

 

 

2,894,137

 

Deferred tax liabilities

 

 

562,534

 

 

562,534

 

Minority interest

 

 

469,727

 

 

497,647

 

Deferred rent

 

 

86,091

 

 

86,425

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock - $.004 par value, 20,000,000 shares authorized, 5,742,670 shares issued at both September 30, 2002 and December 31, 2001

 

 

22,971

 

 

22,971

 

 

Additional paid-in capital

 

 

19,646,388

 

 

19,646,388

 

 

Accumulated earnings

 

 

16,525,815

 

 

16,050,251

 

 

Accumulated other comprehensive income/(loss)

 

 

(37,936

)

 

32,756

 

 

Treasury stock,  at cost, 1,984,450 and 1,631,450 shares at September 30, 2002 and December 31, 2001, respectively

 

 

(12,765,709

)

 

(11,162,849

)

 

 



 



 

 

Total stockholders’ equity

 

 

23,391,529

 

 

24,589,517

 

 

 



 



 

 

 

$

27,312,343

 

$

28,630,260

 

 

 



 



 

See accompanying notes.

3



Table of Contents

MEDSTONE INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 


 


 

 

 

2002

 

2001

 

2002

 

2001

 

 

 



 



 



 



 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Procedures, maintenance fees and fee-for service

 

$

4,600,563

 

$

4,816,951

 

$

13,278,084

 

$

14,076,918

 

 

Net equipment sales

 

 

1,271,401

 

 

1,066,443

 

 

4,779,095

 

 

2,134,302

 

 

Interest income

 

 

84,862

 

 

104,139

 

 

246,506

 

 

362,096

 

 

 

 



 



 



 



 

 

Total revenues

 

 

5,956,826

 

 

5,987,533

 

 

18,303,685

 

 

16,573,316

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of procedures and maintenance fees

 

 

2,604,139

 

 

2,928,207

 

 

7,642,548

 

 

8,438,313

 

 

Cost of equipment sales

 

 

837,740

 

 

683,820

 

 

3,506,676

 

 

1,705,647

 

 

Research and development

 

 

360,304

 

 

319,631

 

 

935,214

 

 

879,735

 

 

Selling

 

 

702,431

 

 

681,465

 

 

2,308,676

 

 

1,925,116

 

 

General and administrative

 

 

708,839

 

 

591,478

 

 

2,360,060

 

 

1,903,783

 

 

 

 



 



 



 



 

 

Total costs and operating expenses

 

 

5,213,453

 

 

5,204,601

 

 

16,753,174

 

 

14,852,594

 

 

 

 



 



 



 



 

 

Operating income

 

 

743,373

 

 

782,932

 

 

1,550,511

 

 

1,720,722

 

Other expense (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of investments

 

 

—  

 

 

(200,169

)

 

—  

 

 

(627,774

)

 

Other expense

 

 

22,942

 

 

47,255

 

 

25,208

 

 

99,631

 

 

 

 



 



 



 



 

 

Total other expense (income):

 

 

22,942

 

 

(152,914

)

 

25,208

 

 

(528,143

)

Minority interests:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Minority interest in subsidiaries income

 

 

191,550

 

 

229,485

 

 

522,080

 

 

564,444

 

 

Equity in (income)/loss  from unconsolidated subsidiaries

 

 

—  

 

 

186,179

 

 

30,359

 

 

149,014

 

 

 

 



 



 



 



 

 

Total minority interest

 

 

191,550

 

 

415,664

 

 

552,439

 

 

713,458

 

 

 



 



 



 



 

Income before provision for income taxes

 

 

528,881

 

 

520,182

 

 

972,864

 

 

1,535,407

 

Provision for income taxes

 

 

301,800

 

 

205,129

 

 

497,300

 

 

639,780

 

 

 



 



 



 



 

Net income

 

$

227,081

 

$

315,053

 

$

475,564

 

$

895,627

 

 

 



 



 



 



 

Earnings per share: